Zithrocare 200: QT interval prolongation may lead to Torsade de Pointes (TdP) and cardiac arrhythmia.
Serious allergic reactions including angioedema, anaphylaxis and dermatologic reactions including Steven-johnson syndrome and toxic epidermal necrolysis have been reported rarely.
Hepatotoxicity.
Clostridium difficile associated diarrhea (CDAD).
Exacerbation of Myasthenia gravis.
Use in sexually transmitted infection.
Development of drug resistant bacteria.
Zithrocare 500: Severe hypersensitivity reactions occur rarely but may be prolonged. Transient reduction in neutrophil count has been seen in patients receiving azithromycin.
Other Services
Country
Account